146 related articles for article (PubMed ID: 7332532)
21. Complementation of genetic disease: a velocity sedimentation procedure for the enrichment of heterokaryons.
Hohmann LK; Shows TB
Somatic Cell Genet; 1979 Nov; 5(6):1013-29. PubMed ID: 545716
[TBL] [Abstract][Full Text] [Related]
22. Genetic heterogeneity of the hexosaminidase deficiency diseases.
Johnson WG
Res Publ Assoc Res Nerv Ment Dis; 1983; 60():215-37. PubMed ID: 6337393
[No Abstract] [Full Text] [Related]
23. Characterization of the testis and epididymis in mouse models of human Tay Sachs and Sandhoff diseases and partial determination of accumulated gangliosides.
Trasler J; Saberi F; Somani IH; Adamali HI; Huang JQ; Fortunato SR; Ritter G; Gu M; Aebersold R; Gravel RA; Hermo L
Endocrinology; 1998 Jul; 139(7):3280-8. PubMed ID: 9645704
[TBL] [Abstract][Full Text] [Related]
24. Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.
Norflus F; Yamanaka S; Proia RL
DNA Cell Biol; 1996 Feb; 15(2):89-97. PubMed ID: 8634145
[TBL] [Abstract][Full Text] [Related]
25. Hereditary heat-labile hexosaminidase B: its implication for recognizing Tay-Sachs genotypes.
Navon R; Nutman J; Kopel R; Gaber L; Gadoth N; Goldman B; Nitzan M
Am J Hum Genet; 1981 Nov; 33(6):907-15. PubMed ID: 6459736
[TBL] [Abstract][Full Text] [Related]
26. cDNA clone for the alpha-chain of human beta-hexosaminidase: deficiency of alpha-chain mRNA in Ashkenazi Tay-Sachs fibroblasts.
Myerowitz R; Proia RL
Proc Natl Acad Sci U S A; 1984 Sep; 81(17):5394-8. PubMed ID: 6236461
[TBL] [Abstract][Full Text] [Related]
27. Tay-Sachs and Sandhoff diseases: enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
Chamoles NA; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2002 Apr; 318(1-2):133-7. PubMed ID: 11880123
[TBL] [Abstract][Full Text] [Related]
28. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
29. Two small deletion mutations of the HEXB gene are present in DNA from a patient with infantile Sandhoff disease.
McInnes B; Brown CA; Mahuran DJ
Biochim Biophys Acta; 1992 Apr; 1138(4):315-7. PubMed ID: 1532910
[TBL] [Abstract][Full Text] [Related]
30. Cleavage of the (1 goes to 3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl linkage present in keratan sulfate. The A and B isoenzymes of human liver hexosaminidase (EC 3.2.1.30).
Toma S; Coppa G; Donnelly PV; Ricci R; Di Ferrante N; Srivastava SK
Carbohydr Res; 1981 Oct; 96(2):271-90. PubMed ID: 6458358
[TBL] [Abstract][Full Text] [Related]
31. [Detection of homozygotes and heterozygote carriers of GM2-gangliosidosis].
Aronovich EL; Krasnopol'skaia KD; Kukharenko VI; Pichugina EM
Genetika; 1986 Aug; 22(8):2179-85. PubMed ID: 3770476
[TBL] [Abstract][Full Text] [Related]
32. In situ assessment of beta-hexosaminidase activity.
Lacorazza HD; Jendoubi M
Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
[TBL] [Abstract][Full Text] [Related]
33. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
Tse R; Vavougios G; Hou Y; Mahuran DJ
Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
[TBL] [Abstract][Full Text] [Related]
34. Hexosaminidase A in amniotic fluid of Tay-Sachs fetuses.
Geiger B; Navon R; Arnon R
Clin Chem; 1978 Jul; 24(7):1131-3. PubMed ID: 657491
[TBL] [Abstract][Full Text] [Related]
35. Prenatal diagnosis for Tay-Sachs disease using chorionic villus sampling.
Grebner EE; Jackson LG
Prenat Diagn; 1985; 5(5):313-20. PubMed ID: 2933645
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of cross-reacting material in Tay-Sachs disease.
Srivastava SK; Ansari NH; Hawkins LA; Wiktorowicz JE
Biochem J; 1979 Jun; 179(3):657-64. PubMed ID: 89845
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
38. [Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].
Tsuji D
Yakugaku Zasshi; 2013; 133(2):269-74. PubMed ID: 23370522
[TBL] [Abstract][Full Text] [Related]
39. Long-term intracellular retention of hexosaminidase A by Tay-Sachs disease brain and lung cells in vitro.
Brooks SE; Hoffman LM; Amsterdam D; Adachi M; Schneck L
J Neurosci Res; 1981; 6(3):381-8. PubMed ID: 6457913
[TBL] [Abstract][Full Text] [Related]
40. The biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.
Mahuran DJ
Biochim Biophys Acta; 1991 Feb; 1096(2):87-94. PubMed ID: 1825792
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
